Genetically Modified Mosquito May Become Weapon Against Zika.

FDA is reviewing Oxitec's application for trial in Florida The U.S. Food and Drug Administration is in the final stages of reviewing an application from Intrexon Corp.'s Oxitec unit to conduct a field trial in the Florida Keys, Oxitec Chief Executive Officer Hadyn Parry said in a phone interview. [Extracted from the article]